Microsoft In Brief This Week: Sophia Genetics, Sense Biodetection, Yourgene, Biodesix, DermTech, Chembio, More News items for the week of Oct. 31, 2022. Microsoft, M2Gen Collaborate on Oncology Analytics for Drug Discovery The partners will scale up M2Gen's ORIEN technology work on the Azure cloud to advance therapeutic development. Deep-Learning Method Helps Predict Sequencing Depth From DNA Probes Premium A novel computational method from NuProbe, Rice University, and Microsoft Research relies on a recurrent neural network to predict sequencing depth with high accuracy. Microsoft Azure Joins NIH STRIDES Cloud Computing Program STRIDES, which already contracts with AWS and Google Cloud, is making Azure AI and machine learning services available to NIH-funded biomedical researchers. Twist Bioscience Reveals MRD Testing Applications, Regeneron Genotyping Project Premium In addition to discussing Twist's liquid biopsy, NGS-based genotyping and SARS-CoV-2 NGS panel, CEO Emily Leproust touted efforts on DNA data storage. Jan 21, 2021 Microsoft Brings Scalability, Apps to Broad and Verily's Terra Bioinformatics Platform Premium Jan 11, 2021 Broad, Verily Extend Terra Bioinformatics Platform to Microsoft Azure Dec 1, 2020 Canadian Consortium Launches COVID Cloud to Support Molecular Research Nov 12, 2020 DNA Data Storage Alliance to Work on Interoperability, Industry Roadmap Oct 15, 2020 Pacific Biosciences, Children's Mercy, Microsoft Collaborate on Rare Genetic Disease Diagnostics Oct 12, 2020 Africa Pathogen Genomics Initiative Launches With $100M Investment Sep 18, 2020 Kaiser Permanente Taps BC Platforms to Analyze Biobank, Clinical Data Premium Jun 12, 2020 New Products Posted to GenomeWeb: Stilla Technologies, Adaptive Biotechnologies, Lexogen, More May 13, 2020 Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19 Premium Apr 2, 2020 Bionano Prices $18M Stock, Warrant Offering Mar 20, 2020 COVID-19 Immune Response to be Mapped by Adaptive Biotechnologies, Microsoft Jan 30, 2020 Neanderthal Genetic Ancestry Found in Present-Day African Populations Nov 6, 2019 Jax, Microsoft Team to Mine Medical Literature for Curating Clinical Knowledgebase Premium Jul 11, 2019 Microsoft, Seattle Children's Seek Genetic Markers for SIDS Through Whole-Genome Sequencing Premium Jan 9, 2019 Adaptive Biotechnologies to Leverage Genentech, Microsoft Deals to Advance Immune Profiling Business Oct 26, 2018 Lung Cancer Liquid Biopsy Approach Marries Sequencing, Target Enrichment, Computational Methods Premium Oct 18, 2018 Microsoft Expands Azure Software Ecosystem With New Informatics Partnerships Premium Apr 17, 2018 St. Jude Opens Its Pediatric Cancer Sequencing Data to Researchers Worldwide Premium Jan 30, 2018 UPDATE: Multi-Omics Researchers Among Recipients of New Stand Up to Cancer Awards Jan 4, 2018 Microsoft, Adaptive Biotechnologies Partner to Study Immune System Genetics Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.